Decrease of regulatory T cells in patients with systemic lupus erythematosus.
作者信息
Mellor-Pita S, Citores M J, Castejon R, Tutor-Ureta P, Yebra-Bango M, Andreu J L, Vargas J A
出版信息
Ann Rheum Dis. 2006 Apr;65(4):553-4. doi: 10.1136/ard.2005.044974.
Abstract
摘要
相似文献
1
Decrease of regulatory T cells in patients with systemic lupus erythematosus.
Ann Rheum Dis. 2006 Apr;65(4):553-4. doi: 10.1136/ard.2005.044974.
2
Disturbed Th1, Th2, Th17 and T(reg) balance in patients with systemic lupus erythematosus.
Clin Immunol. 2011 Nov;141(2):197-204. doi: 10.1016/j.clim.2011.08.005. Epub 2011 Aug 16.
3
Role of Treg cells and TGF-β1 in patients with systemic lupus erythematosus: a possible relation with lupus nephritis.
Immunol Invest. 2012;41(1):15-27. doi: 10.3109/08820139.2011.578189. Epub 2011 May 12.
4
Systemic lupus erythematosus exhibits a dynamic and continuum spectrum of effector/regulatory T cells.
Scand J Rheumatol. 2011 Jan;40(1):41-50. doi: 10.3109/03009742.2010.489229. Epub 2010 Oct 11.
5
Follicular Regulatory T Cells in Systemic Lupus Erythematosus.
J Immunol Res. 2021 Jul 13;2021:9943743. doi: 10.1155/2021/9943743. eCollection 2021.
6
The ratio of circulating follicular T helper cell to follicular T regulatory cell is correlated with disease activity in systemic lupus erythematosus.
Clin Immunol. 2017 Oct;183:46-53. doi: 10.1016/j.clim.2017.07.004. Epub 2017 Jul 12.
7
The tolerogenic peptide hCDR1 downregulates pathogenic cytokines and apoptosis and upregulates immunosuppressive molecules and regulatory T cells in peripheral blood mononuclear cells of lupus patients.
Hum Immunol. 2009 Mar;70(3):139-45. doi: 10.1016/j.humimm.2009.01.018.
8
CD4(+)CD25 (+) regulatory T cells in human lupus erythematosus.
Arch Dermatol Res. 2009 Jan;301(1):71-81. doi: 10.1007/s00403-008-0891-9. Epub 2008 Nov 5.
9
Regulatory T cells and systemic lupus erythematosus.
Ann N Y Acad Sci. 2007 Jun;1108:64-75. doi: 10.1196/annals.1422.007.
10
Relationship between T lymphocyte subsets and cortisol in systemic lupus erythematosus.
Kathmandu Univ Med J (KUMJ). 2009 Jul-Sep;7(27):213-9. doi: 10.3126/kumj.v7i3.2726.
引用本文的文献
1
Regulatory T Cell Sub-Populations in Patients with Distinct Autoimmune/Inflammatory Diseases With or Without Inborn Errors of Immunity.
Diagnostics (Basel). 2025 Jul 26;15(15):1879. doi: 10.3390/diagnostics15151879.
2
Suppression of skin lesions and SLE nephritis by increasing Treg in MRL/FAS mice by administration of bee venom Apitoxin.
Adv Rheumatol. 2025 Mar 19;65(1):17. doi: 10.1186/s42358-025-00448-5.
3
Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.
Front Immunol. 2025 Feb 5;16:1449693. doi: 10.3389/fimmu.2025.1449693. eCollection 2025.
4
Dose effect of corticosteroids on peripheral lymphocyte profiles in patients with systemic lupus erythematosus.
Clin Rheumatol. 2025 Feb;44(2):669-679. doi: 10.1007/s10067-024-07254-2. Epub 2025 Jan 6.
5
Autoimmune disease: a view of epigenetics and therapeutic targeting.
Front Immunol. 2024 Nov 13;15:1482728. doi: 10.3389/fimmu.2024.1482728. eCollection 2024.
6
Clinical significance of antinuclear antibody as prognostic marker for first-line pembrolizumab in advanced non-small cell lung cancer.
Int J Clin Oncol. 2024 Feb;29(2):124-133. doi: 10.1007/s10147-023-02445-4. Epub 2023 Dec 31.
7
Pathogenesis and novel therapeutics of regulatory T cell subsets and interleukin-2 therapy in systemic lupus erythematosus.
Front Immunol. 2023 Sep 12;14:1230264. doi: 10.3389/fimmu.2023.1230264. eCollection 2023.
8
Allogeneic cord blood regulatory T cells decrease dsDNA antibody and improve albuminuria in systemic lupus erythematosus.
Front Immunol. 2023 Sep 5;14:1217121. doi: 10.3389/fimmu.2023.1217121. eCollection 2023.
9
T cells in health and disease.
Signal Transduct Target Ther. 2023 Jun 19;8(1):235. doi: 10.1038/s41392-023-01471-y.
10
Impact of dietary vitamin D on immunoregulation and disease pathology in lupus-prone NZB/W F1 mice.
Front Immunol. 2022 Nov 24;13:933191. doi: 10.3389/fimmu.2022.933191. eCollection 2022.
本文引用的文献
1
T cells in the pathogenesis of systemic lupus erythematosus.
Clin Immunol. 2004 Oct;113(1):4-13. doi: 10.1016/j.clim.2004.05.001.
2
Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses.
Annu Rev Immunol. 2004;22:531-62. doi: 10.1146/annurev.immunol.21.120601.141122.
3
Decreased CD4+CD25+ T cells in peripheral blood of patients with systemic lupus erythematosus.
Scand J Immunol. 2004 Feb;59(2):198-202. doi: 10.1111/j.0300-9475.2004.01370.x.
4
Quantification of regulatory T cells in patients with systemic lupus erythematosus.
J Autoimmun. 2003 Nov;21(3):273-6. doi: 10.1016/s0896-8411(03)00121-5.
5
CD4+CD25high regulatory cells in human peripheral blood.
J Immunol. 2001 Aug 1;167(3):1245-53. doi: 10.4049/jimmunol.167.3.1245.
6
Regulatory T cells in autoimmmunity*.
Annu Rev Immunol. 2000;18:423-49. doi: 10.1146/annurev.immunol.18.1.423.
7
8
The 1982 revised criteria for the classification of systemic lupus erythematosus.
Arthritis Rheum. 1982 Nov;25(11):1271-7. doi: 10.1002/art.1780251101.
9
Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE.
Arthritis Rheum. 1992 Jun;35(6):630-40. doi: 10.1002/art.1780350606.
Zotero 插件